Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01495546
Other study ID # CAPPesq0303
Secondary ID
Status Recruiting
Phase N/A
First received December 12, 2011
Last updated September 13, 2012
Start date December 2011
Est. completion date December 2012

Study information

Verified date September 2012
Source University of Sao Paulo
Contact Gisele P Mantelli
Phone 55 11 3069-6442
Email gpmantelli@yahoo.com.br
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

In Brazil, several hip surgeries performed, especially total knee arthroplasty, which represents 1.5 million procedures (Penedo, New, 2007). The rehabilitation of these individuals is slow with respect to the march because it requires an aid and not to use the operated leg as support for three weeks, according to conventional methods. After the third week, the support becomes part and after that period (sixth week), the support becomes total. Therefore, and in order to provide better quality of life, the goal of this work is to compare the march in 40 patients divided into two groups of 20 subjects each. In the control group, the treatment approach is the traditional, i.e., without immediate loading, while the other charge will be applied immediately in the operated limb. In order to verify the possible gain in the quality of life of these patients, the SF-36 will be applied. The march will be assessed with the Time Up and Go test and the force platform and the Harris Hip score analyze the function of the hip. Individuals will receive such care at the Institute of Orthopedics and Traumatology, Hospital das Clinicas, Faculty of Medicine, University of São Paulo (IOT - HC - USP). The results of comparisons between the two groups and the clinical findings obtained will be subjected to appropriate statistical tests, guided by the principles of evidence-based clinical practice, seeking to facilitate and improve the lives of these individuals so they can move freely.


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 30 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients served by the institution with THA without cement;

- BMI less than 40, ie, present in most class II obesity;

- Patients with diseases such as osteoarthritis and osteonecrosis of the femoral head;

- Absence of systemic involvement;

- Patients with prosthetic type Lépine.

Exclusion Criteria:

- Bilateral arthroplasty;

- Partial arthroplasty;

- Arthroplasties for review;

- Cemented arthroplasties;

- Surgical complications.

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
Early loading
Patients stepping down immediately after THA
Late loading
Patients stepping down after three weeks of HTA

Locations

Country Name City State
Brazil Institute of Orthopedics and Traumatology, Hospital das Clinicas, Faculty of Medicine, University of Sao Paulo Sao Paulo

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recovery time after THA Patients will be evaluated in the following periods: THA pre-surgery, the third day post-surgery THA, third and sixth week post-surgery THA, third and sixth months after surgery THA Until 6 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT03968939 - Total Joint Arthroplasty and Sleep Phase 4
Terminated NCT04036071 - Clinical Observation Study of the Hydroxylapatite-coated SLPLUS™MIA Hip Shaft
Completed NCT04209426 - Retrospective Observational Cohort Study of SYMBOL CUP DM 2
Enrolling by invitation NCT05313321 - Survival of the Insignia Stem in Total Hip Arthroplasty
Terminated NCT04121585 - Clinical Observation Study of the Hydroxylapatite-coated SL-PLUS™ Hip Shaft
Completed NCT03690037 - Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty Phase 4
Completed NCT04209374 - Retrospective Observational Cohort Study of SYMBOL CUP DM 1
Completed NCT04122157 - Prospective Single-center Long-term Observation of the SL-PLUS® MIA Stem
Completed NCT04085640 - Obturator Nerve Block in Total Hip Arthrosplasty N/A
Recruiting NCT04319952 - OPS™ With Direct Anterior Approach (DAA)
Completed NCT05072704 - Opioid Free Anesthesia in Total Hip Arthroplasty Phase 3
Completed NCT03973320 - Outcomes After Hypotensive Neuraxial Anesthesia in Total Hip Arthroplasty
Terminated NCT02933671 - Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty Phase 4
Completed NCT03956381 - Accuracy of OPS™ Femoral Neck Resection Study